IV Nitroglycerin Dosing Protocol for Chest Pain
Start IV nitroglycerin at 10 mcg/min and titrate by 10 mcg/min every 3-5 minutes until pain relief or hemodynamic response is achieved, ensuring systolic blood pressure remains ≥90 mm Hg. 1
Initial Dosing Algorithm
Starting dose: 10 mcg/min (or 5 mcg/min if using non-absorbing tubing) 1, 2, 3
Titration schedule:
- Increase by 10 mcg/min every 3-5 minutes 2
- If no response at 20 mcg/min, increase by 10-20 mcg/min increments 2
- Once partial blood pressure response occurs, reduce increment size and lengthen intervals between increases 2
Maximum dose: Commonly 200 mcg/min, though doses up to 400 mcg/min are FDA-approved 2, 3
Critical Safety Parameters
Absolute contraindications:
- Systolic blood pressure <90 mm Hg or ≥30 mm Hg below baseline 1, 4
- Suspected right ventricular infarction 1, 4
- Recent phosphodiesterase-5 inhibitor use:
Relative contraindications:
- Severe bradycardia (<50 bpm) or tachycardia (>100 bpm) 4
Clinical Indications
Use IV nitroglycerin for:
- Persistent anginal pain after sublingual nitroglycerin (3 doses of 0.3-0.4 mg) 1, 4
- ACS accompanied by hypertension 1
- ACS with pulmonary edema 1, 4
The 2025 ACC/AHA guidelines 1 represent the most current evidence and clearly specify starting at 10 mcg/min (not the older 5 mcg/min recommendation), though the FDA label 3 notes that non-absorbing tubing requires lower initial doses (5 mcg/min) because PVC tubing absorbs significant amounts of nitroglycerin.
Monitoring Requirements
Target blood pressure response:
- Do NOT reduce systolic BP below 110 mm Hg in normotensive patients 2
- Do NOT reduce mean arterial pressure by >25% in hypertensive patients 2
Continuous monitoring required:
- Blood pressure and heart rate in all patients 3
- Pulmonary capillary wedge pressure when appropriate 3
Important Pitfalls
Tachyphylaxis: Develops after approximately 24 hours of continuous infusion 1. If therapy extends beyond 24 hours, periodic dose increases may be needed to maintain efficacy 2.
Tubing considerations: The type of administration set significantly affects drug delivery. Non-absorbing (non-PVC) tubing delivers more drug than PVC tubing, requiring dose adjustment 3. Most modern studies used non-absorbing tubing, supporting the 10 mcg/min starting dose.
Hypersensitive patients: Those with normal or low left ventricular filling pressures may respond fully to doses as small as 5 mcg/min and require especially careful titration 3.
Transition Strategy
Once patients are pain-free for 12-24 hours, attempt to reduce IV nitroglycerin and transition to oral or topical nitrates 2. Do not continue IV therapy in patients who remain free of ischemic signs and symptoms 2.
Recent research 5, 6 suggests that higher-dose nitroglycerin (≥100 mcg/min) in acute pulmonary edema results in faster symptom resolution without increased hypotension risk, though these findings primarily apply to sympathetic crashing acute pulmonary edema rather than typical ACS presentations.